LAVA Therapeutics NV Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2024 to Q2 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
LAVA Therapeutics NV quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2024 to Q2 2025.
- LAVA Therapeutics NV Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 26.9M shares, a 0.29% increase year-over-year.
- LAVA Therapeutics NV annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 26.8M shares, a 0.38% increase from 2023.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)